𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review

✍ Scribed by Aikaterini-Evaggelia Moustou; Athina Matekovits; Clio Dessinioti; Christina Antoniou; Petros P. Sfikakis; Alexander J. Stratigos

Book ID
116584556
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
232 KB
Volume
61
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiangiogenic effects of anti–tumor nec
Antiangiogenic effects of anti–tumor necrosis factor α therapy with infliximab in psoriatic arthritis
✍ Juan D. Cañete; José L. Pablos; Raimon Sanmartí; Carmen Mallofré; Sara Marsal; J 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana

Physician preference motivates the use o
Physician preference motivates the use of anti–tumor necrosis factor therapy independent of clinical disease activity
✍ Jeffrey R. Curtis; Lang Chen; Leslie R. Harrold; Pongthorn Narongroeknawin; Geor 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Objective Physician preference has previously been shown to be an important determinant of prescription patterns, independent of patient‐specific factors. We evaluated whether physician preference was important in the decision to select anti–tumor necrosis factor (anti‐TNF) therapy